The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Rapaport, M. H.
* Articles by Clary, C.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Rapaport, M. H.
* Articles by Clary, C.
Related Collections
* Panic Disorder
* Anxiolytics
Am J Psychiatry 157:1014-1016, June 2000
© 2000 American Psychiatric Association


Brief Report

Is Placebo Response the Same as Drug Response in Panic Disorder?

Mark Hyman Rapaport, M.D., Mark Pollack, M.D., Robert Wolkow, M.D., Jack Mardekian, Ph.D., and Cathryn Clary, M.D.

OBJECTIVE: The authors used seven definitions of response in panic disorder to compare patient-rated improvements in quality of life between patients with panic disorder who responded to sertraline and those who responded to placebo.METHOD: They combined and examined data from two multicenter, randomized, double-blind, parallel-group, flexible-dose studies of panic disorder (N=302).RESULTS: Significant differences in quality of life between patients who responded to sertraline and those who responded to placebo were apparent across all the definitions of clinical response.CONCLUSIONS: Patients who respond to placebo in panic disorder treatment studies may show symptom relief but may not experience improvement in quality of life. Determinations of quality of life should be included as components of both standard clinical assessment and clinical treatment studies of patients with panic disorder.




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
M. H. Trivedi, A. J. Rush, S. R. Wisniewski, A. A. Nierenberg, D. Warden, L. Ritz, G. Norquist, R. H. Howland, B. Lebowitz, P. J. McGrath, et al.
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
Am J Psychiatry, January 1, 2006; 163(1): 28 - 40.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. H. Kocsis, A. Schatzberg, A. J. Rush, D. N. Klein, R. Howland, L. Gniwesch, S. M. Davis, and W. Harrison
Psychosocial Outcomes Following Long-term, Double-blind Treatment of Chronic Depression With Sertraline vs Placebo
Arch Gen Psychiatry, August 1, 2002; 59(8): 723 - 728.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org